- Company Directors - K
- Kelley Willam N
Insider Trading History of Kelley Willam N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kelley Willam N since 2006.
The trader's CIK number is 1204361.
At the time of the last reporting, Kelley Willam N was the Director of Transenterix, Inc.. (stock ticker symbol TRXC).
Also see all insider trading activities at Transenterix, Inc..
Note that in the past
KELLEY WILLAM N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Transenterix, Inc. (TRXC) by Kelley Willam N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | TRXC | 30,000 | $21,180 | 0 | $0 | 0 | $0 |
2015 | TRXC | 20,000 | $55,899 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Beckman Coulter Inc (BEC) by Kelley Willam N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | BEC | 0 | $0 | 0 | $0 | 5,000 | $186,725 |
2010 | BEC | 0 | $0 | 5,000 | $314,000 | 5,000 | $253,000 |
2009 | BEC | 0 | $0 | 9,000 | $550,890 | 9,000 | $247,348 |
2008 | BEC | 0 | $0 | 4,000 | $265,064 | 4,000 | $116,248 |
2007 | BEC | 0 | $0 | 2,000 | $126,050 | 2,000 | $41,186 |
2006 | BEC | 0 | $0 | 2,000 | $106,500 | 2,000 | $40,562 |
Yearly summary of insider trading at Merck & Co Inc (MRK) by Kelley Willam N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | MRK | 0 | $0 | 1,964 | $87,456 | 2,110 | $87,375 |
2006 | MRK | 0 | $0 | 1,750 | $60,584 | 2,110 | $59,999 |
2002 | MRK | 750 | $27,398 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genvec Inc (GNVC) by Kelley Willam N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | GNVC | 0 | $0 | 0 | $0 | 1,500 | $5,700 |
Insider trading activities at 4 companies by Kelley Willam N:
1. Transenterix, Inc. (TRXC)
2. Beckman Coulter Inc (BEC)
3. Merck & Co Inc (MRK)
4. Genvec Inc (GNVC)
Table 1. Insider trading of Transenterix, Inc. (TRXC) by Kelley Willam N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-08-08 | TRXC | Buy | 30,000 | .71 | 21,180 |
2015-11-12 | TRXC | Buy | 10,000 | 2.78 | 27,799 |
2015-11-13 | TRXC | Buy | 10,000 | 2.81 | 28,100 |
Table 2. Insider trading of Beckman Coulter Inc (BEC) by Kelley Willam N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-02-04 | BEC | Option Ex | 5,000 | 37.34 | 186,725 |
2010-04-01 | BEC | Sale | 5,000 | 62.80 | 314,000 |
2010-04-01 | BEC | Option Ex | 5,000 | 50.60 | 253,000 |
2009-08-25 | BEC | Option Ex | 5,000 | 31.92 | 159,600 |
2009-08-25 | BEC | Sale | 5,000 | 68.25 | 341,250 |
2009-05-22 | BEC | Sale | 4,000 | 52.41 | 209,640 |
2009-03-10 | BEC | Option Ex | 4,000 | 21.94 | 87,748 |
2008-05-05 | BEC | Sale | 4,000 | 66.27 | 265,064 |
2008-03-18 | BEC | Option Ex | 4,000 | 29.06 | 116,248 |
2007-03-01 | BEC | Option Ex | 2,000 | 20.59 | 41,186 |
2007-03-01 | BEC | Sale | 1,800 | 63.03 | 113,446 |
2006-03-01 | BEC | Sale | 200 | 63.02 | 12,604 |
2006-03-15 | BEC | Sale | 2,000 | 53.25 | 106,500 |
2006-03-15 | BEC | Option Ex | 2,000 | 20.28 | 40,562 |
Table 3. Insider trading of Merck & Co Inc (MRK) by Kelley Willam N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2002-09-24 | MRK | Buy | 200 | 45.65 | 9,130 |
2006-01-18 | MRK | Buy | 550 | 33.22 | 18,268 |
2007-02-06 | MRK | Sale | 1,964 | 44.53 | 87,456 |
2007-02-06 | MRK | Option Ex | 2,110 | 41.41 | 87,375 |
2006-02-14 | MRK | Option Ex | 2,110 | 28.44 | 59,999 |
2006-02-14 | MRK | Sale | 1,750 | 34.62 | 60,584 |
Table 4. Insider trading of Genvec Inc (GNVC) by Kelley Willam N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-06-16 | GNVC | Option Ex | 1,500 | 3.80 | 5,700 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kelley Willam N
(Director of Transenterix, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.